The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors

被引：0
|
作者：
Sivasree Kesana
Perumal Kalaiyarasi Jayachandran
Gangothri Selvarajan
Subramaniam Murali Carthikeyan
Venkatraman Radhakrishnan
Tenali Gnana Sagar
Trivadi Sundaram Ganesan
机构：
[1] Cancer Institute (W.I.A),Department of Medical Oncology
[2] Cancer Institute (WIA),Department of Medical Oncology
来源：
Indian Journal of Gynecologic Oncology | 2023年 / 21卷
关键词：
Ovarian GCT; Relapsed/Refractory ovarian germ cell tumor; Salvage chemotherapy; Irinotecan; Paclitaxel and Oxaliplatin (IPO); Cisplatin ineligible Ovarian GCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and safety of gemcitabine, oxaliplatin and paclitaxel (GOP) in cisplatin-refractory germ cell tumors in routine care: Registry data from an outcomes research project
    Seidel, Christoph Alexander
    Lorch, Anja
    Dieing, Annette
    Hentrich, Marcus
    Hornig, Mareike
    Gruenwald, Viktor
    Cathomas, Richard
    Meiler, Johannes
    De Wit, Maike
    Bokemeyer, Carsten
    Oechsle, Karin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors
    Narayan, Vivek
    Gunnarsson, Orvar
    Hwang, Wei -Ting
    Squillante, Christian M.
    Nathanson, Katherine L.
    Stadtmauer, Edward A.
    Vaughn, David J.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (06) : 524 - 529
  • [23] Long term outcome in patients with cisplatin-refractory or multiply relapsed germ cell tumors following treatment with gemcibine and oxaliplatin ± paclitaxel.
    Oechsle, K.
    Kollmannsberger, C. K.
    Honecker, F.
    Mayer, F.
    Waller, C. F.
    Boehlke, I.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Oxaliplatin, Irinotecan, and Gemcitabine: A Novel Combination in the Therapy of Progressed, Relapsed, or Refractory Tumors in Children
    Hartmann, Carolin
    Weinel, Peter
    Schmid, Hansjoerg
    Grigull, Lorenz
    Sander, Anette
    Linderkamp, Christin
    Welte, Karl
    Reinhardt, Dirk
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (05) : 344 - 349
  • [25] Combination salvage chemotherapy for refractory germ cell tumors
    Nature Clinical Practice Urology, 2007, 4 (3): : 119 - 119
  • [26] SALVAGE CHEMOTHERAPY FOR REFRACTORY GERM-CELL TUMORS
    VOGELZANG, NJ
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 471 - 471
  • [27] Vincristine, irinotecan, and temozolomide as a salvage regimen for relapsed or refractory sarcoma in children and young adults.
    Park, Byung-Kiu
    Ju, Hee Young
    Park, Meerim
    Park, Hyeon Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Salvage Chemotherapy for Patients With Germ Cell Tumors: Is There a Best Regimen?
    Einhorn, Lawrence Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 771 - 772
  • [29] Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma
    Ozdemir, Evren
    Aslan, Alma
    Turker, Alev
    Barista, Ibrahim
    Kars, Ayse
    BLOOD, 2015, 126 (23)
  • [30] The efficacy and safety of irinotecan plus doxorubicin liposome in relapsed/refractory Wilms' tumors: A retrospective study.
    Wang, Juan
    Zhang, Lian
    Que, Yi
    Zhen, Zijun
    Zhu, Jia
    Sun, Feifei
    Lu, Suying
    Huang, Junting
    Wu, Liuhong
    Cai, Ruiqing
    Zhang, Yizhuo
    Sun, Xiaofei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345